ABBV vs BMY
AbbVie vs Bristol Myers Squibb — AI-powered side-by-side comparison
| Metric | ABBV | BMY |
|---|---|---|
| AI Score | 52 | 61 |
| Price | $243.70 | $65.92 |
| P/E Ratio | 69.05× | 14.42× |
| ROE | -129.2% | 38.2% |
| Revenue Growth YoY | — | — |
| Gross Margin | 74.1% | 70.2% |
| Debt / Equity | 2.47× | 1.93× |
| Dividend Yield | 2.8% | 3.8% |
| RSI (14) | 33.5 | 80.2 |
| Beta | 0.28 | 0.235 |
| Expected Upside | — | +1.2% |
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
ABBV Full Analysis
BMY Full Analysis